A newly formed Ottawa-based medical cannabis company says it’s purchased the assets of another local pot firm as it builds out an R&D operation and explores genetic engineering methods to produce pharmaceutical-grade marijuana.
Fairway Green Cannabis was launched earlier this month and is headed by Michael Inskip, a former high-tech sales and marketing executive who later led a capital pool company, Thoroughbred Capital. Fairway Green Cannabis says it plans to cultivate cannabis for medical and pharmaceutical applications as well as invest heavily in R&D, including “alternative growing strategies,” engineered enzymes and tailored genetics.
The company’s leadership team also includes local intellectual property lawyer Gordon Freedman.
(Sponsored)
Invest with confidence: Hydro Ottawa funds technical studies for business retrofits
For Ottawa businesses, the opportunity to improve building performance has never been greater. Energy retrofits can cut emissions, strengthen operations, extend the life of assets, reduce operating costs, and position
Inspired by love and loss, donor Tom Moore triples Giving Tuesday donations
For Tom Moore, a retired tech executive and longtime Ottawa resident, giving back to The Ottawa Hospital isn’t just a gesture of generosity. It’s personal. Tom grew up on a
This week, Fairway Green Cannabis said it was acquiring the assets of NordikLeaf, a local cannabis company led by Ottawa entrepreneur James MacKenzie. NordikLeaf secured a 25-acre property outside Perth in 2019 that it intended to convert to cannabis cultivation.
Terms of the transaction were not disclosed.
Fairway Green Cannabis says it’s in the process of obtaining a cannabis production licence from Health Canada.
